/
WHOOPING COUGH DR JAYAPRAKASH. K.P WHOOPING COUGH DR JAYAPRAKASH. K.P

WHOOPING COUGH DR JAYAPRAKASH. K.P - PowerPoint Presentation

emmy
emmy . @emmy
Follow
345 views
Uploaded On 2022-05-18

WHOOPING COUGH DR JAYAPRAKASH. K.P - PPT Presentation

ASSOPROFPEDIATRICS ICHGOVT MEDICAL COLLEGEKOTTAYAM LEARNING OBJECTIVES To write 2 agents causing whoop like cough To list 2 clinical features of whooping cough To name 3 complication of whooping cough ID: 911686

cough pertussis days age pertussis cough age days paroxysmal suspected stage respiratory paroxysms clinical viruses contacts close whooping catarrhal

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "WHOOPING COUGH DR JAYAPRAKASH. K.P" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

WHOOPING COUGH

DR JAYAPRAKASH. K.P

ASSO.PROF.PEDIATRICS

ICH,GOVT MEDICAL COLLEGE,KOTTAYAM

Slide2

LEARNING OBJECTIVES

To write 2 agents causing whoop like cough

To list 2 clinical features of whooping cough

To name 3 complication of whooping cough

To suggest 2 preventive measures

Slide3

AETIOLOGY

Bordetella pertussis is the cause of epidemic pertussis and the usual cause of sporadic pertussis

Slide4

Protracted coughing (which in some cases is paroxysmal) can be caused by Mycoplasma, parainfluenza viruses, influenza viruses, enteroviruses, respiratory syncytial viruses, or adenoviruses.

Slide5

PATHOGENESIS

Bordetella organisms are small, fastidious, Gram-negative coccobacilli that colonize only ciliated epithelium. The exact mechanism of disease symptomatology remains unknown

Only B. pertussis expresses pertussis toxin (PT), the major virulence protein.

Slide6

filamentous hemagglutinin

, some

agglutinogens

(especially fimbriae [

Fim

] types 2 and 3), and a 69-kDa

nonfimbrial

surface protein

called

pertactin

(Prn)

are important for attachment to ciliated respiratory epithelial cells.

Tracheal

cytotoxin,adenylate

cyclase, and PT appear to inhibit clearance of organisms

Slide7

CLINICAL FEATURES

Classically, pertussis is a prolonged disease, divided into

catarrhal,paroxysmal

, and convalescent stages.

The catarrhal stage (1-2

wk

) begins insidiously after an incubation period ranging from 3-12 days with

nondistinctive

symptoms of congestion and

rhinorrhea

variably accompanied by low-grade fever, sneezing, lacrimation, and conjunctival suffusion.

Slide8

As initial symptoms wane, coughing marks the onset of the paroxysmal stage (2-6

wk

).

The cough begins as a dry, intermittent,

irritative

hack and evolves into the inexorable paroxysms that are the hallmark of pertussis.

Slide9

Posttussive

emesis

is common, and exhaustion is universal. The number

and severity of paroxysms escalate over days to a week and

remain at that plateau for days to weeks.

. As the paroxysmal stage fades into the convalescent stage (≥2

wk

), the number, severity, and duration of episodes diminish.

Slide10

Infants younger than 3

mo

of age do not display the classic stages

.

The catarrhal phase lasts only a few days or is unnoticed, and then, after the most insignificant startle from a draft, light, sound, sucking, or stretching, a well-appearing young infant begins to choke, gasp,

gag,and

flail the extremities, with face reddened

Slide11

DIAGNOSIS

A clinical case definition

of cough of 14 days

or longer duration with

at least 1 associated symptom of paroxysms, whoop, or

posttussivevomiting

has a sensitivity of 81% and a specificity of 58% for confirmation of pertussis.

Slide12

Pertussis should be suspected

in any individual who has a pure or predominant complaint of cough, especially

if the following

featuresare

absent: fever, malaise or myalgia,

exanthem

or

enanthem

, sore throat, hoarseness,

tachypnea

, wheezes, and rales

Slide13

TREATMENT

Infants younger than 3

mo

of age with suspected pertussis usually are admitted to hospital, as are many between 3 and 6

mo

of age unless witnessed paroxysms are not severe, as well as are patients of any age

if significant complications occur.

Slide14

Assessing the need to provide oxygen, stimulation, or suctioning requires skilled personnel who can watchfully observe an infant’s ability for self-rescue but who will intervene rapidly and expertly when necessary

Slide15

An antimicrobial agent always is given when pertussis is suspected or confirmed, primarily to limit the spread of infection and

secondarilyfor

possible clinical benefit. Macrolides are preferred agents and are similar to one another in terms of in vitro activity

Slide16

Azithromycin is the preferred

Isolation

Patients with suspected pertussis are placed in isolation with droplet precautions to reduce close respiratory or mucous membrane contact with respiratory secretions.

All healthcare personnel should wear a mask upon entering the room.

Slide17

Care of Household and Other Close Contacts

A macrolide agent should be given promptly to all household contacts and other close contacts, such as those in

daycare

, regardless of age, history of immunization, and symptoms

Slide18

COMPLICATIONS

The principal complications of pertussis are

apnea

, secondary infections (such as otitis media and pneumonia

Expected pathogens include Staphylococcus aureus, Streptococcus pneumoniae, and bacteria of oropharyngeal flora.

Slide19

PREVENTION

Universal immunization of children with pertussis vaccine, beginning in infancy with reinforcing dose(s) through adolescence

Slide20

OMP

Slide21